JUDGMENT
PER CURIAM.
This Cause having been heard and considered, it is Ordered and Adjudged:
AFFIRMED. See Fed. Cir. R. 36.
In re OMEPRAZOLE PATENT LITIGATION. Astrazeneca AB, Aktiebolaget Hassle, KBI-E, Inc., KBI, Inc., and Astrazeneca LP, Plaintiffs-Appellees, v. Mylan Laboratories Inc. (now known as Mylan Inc.), Mylan Pharmaceuticals Inc., Laboratorios Dr. Esteve, S.A. and Esteve Quimica, S.A., Defendants-Appellants
412 F. App'x 297
Authorities cited
No cited authorities resolved to law.co cases yet.